Abstract:C-reactive protein (CRP) is a sensitive marker of inflammation, and elevated levels have been associated with future risk of cardiovascular events. To explore the role and relationship of CRP and coronary stenosis in the development of unstable angina (UA), plasma levels of CRP were determined on admission in 45 patients with UA, and in 42 patients with stable angina (SA) using high-sensitivity ELISA. Coronary angiography was performed in all patients with coronary heart disease (CHD), and severity of coronary stenosis was evaluated by a quantitative analysis. Lipid measurement was performed using automatic biochemical analyzer. Data available from patients with CHD were compared with those of 41 control subjects. The results showed that plasma levels of CRP are significantly higher in patients with UA than those in patients with SA and control subjects (5.1 +/- 1.4 mg/L vs 1.7 +/- 0.4 mg/L and 1.3 +/- 0.2 mg/L, p < 0.01, respectively) with no difference between the latter two groups (p > 0.05); the total incidence of clinical events during in-hospital follow-up was higher in the group A (p < 0.01); the scores of coronary stenosis are significantly higher in patients with SA than those in patients with UA (4.9 &PLUSMN; 2.1 vs 3.4 &PLUSMN; 1.4, p&LT;0.05); there is no correlation between plasma levels of CRP and serum total cholesterol (TC) as well as high-density lipoprotein cholesterol (HDL-C) in both groups (p&GT;0.05 respectively); there was no correlation between plasma levels of CRP and severity of coronary stenosis was found in patients with UA (p&GT;0.05) but a significant positive association in patients with SA (p&LT;0.001); and the patients with persistent, severe, treatment-unresponsive UA had significantly higher CRP levels as well as incidence of clinical events than patients with treatment-responsive UA (7.4 &PLUSMN; 1.8 mg/L vs 2.6 &PLUSMN; 1.3 mg/L, p&LT;0.01; 0 vs 22.2%, p&LT;0.05). The present data suggested that inflammation may play an important role in the pathogenesis of UA, and the plasma levels of CRP might have a higher prognostic value than the severity of coronary stenosis correlated with the clinical outcome of instability despite of lipid profile status.

Changes of the Serum Level of C-reactive Protein after Coronary Angioplasty

The Serum Levels of High Sensitivity C-reactive Protein and Cardiac Events after Percutaneous Coronary Intervention

The Change and Clinical Significance of Serum Tumor Necrosis Factor-Α、interleukin-6 and Interleukin-8 after Cutting Balloon Angioplasty and Stent Implantation

Changes of C Reactive Protein Level in Patients with Coronary Heart Disease after Percutaneous Coronary Intervention

Predictive Value of Baseline C-reactive Protein for Periprocedural Myocardial Infraction of Higher Risk Stratifications: A Retrospective Cohort Clinical Study

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Relationship Between the High-Sensitivity C-reactive Protein,cardiac Troponin I and Severity of Coronary Lesion

Changes of Plasma P-selectin、 Thrombomodulin、 Plasminogen Activator Inhibitor-1 of Coronary Artery Disease Patients Before and after PTCA

[Changes of Plasma High-Sensitive C-reactive Protein and Monocyte Chemotactic Factor-1 Following Percutaneous Coronary Interventional Procedures in Patients with Coronary Artery Disease].

The effect on vascular endothelial growth factor and C-reactive protein levels before and after coronary intervention treatment of coronary heart disease

Changes of serum cardiac troponin levels after percutaneous transluminal coronary angioplasty and its re-lation to late cardiac events

Relationship of Preprocedural High Sensitivity C-reactive Protein and Restenosis after Coronary Angioplasty of Unprotected Left Main Coronary Artery Stenosis

The Changes of Serum C-reactive Protein Level in Patients with Coronary Artery Disease and Its Clinical Significance

The Value of Preprocedural Serum Levels of C-reactive Protein in Predicting Cardiovascular Events and Restenosis after Coronary Stent Implantation

Serum concentrations of high-sensitivity C-reactive protein predict progressively obstructive lesions rather than late restenosis in patients with unstable angina undergoing coronary artery stenting

Effects of Percutaneous Transluminal Coronary Angioplasty on Serum Soluble Intercellular Adhesion Molecule-1 and P-selectin Levels

Temporal Changes in Circulating P-selectin, Plasminogen Activator Inhibitor-1, Magnesium, and Creatine Kinase after Percutaneous Coronary Intervention

Relevance of C-reactive Protein to Coronary Arterial Lesions of Unstable Angina Patients and the Predicting Value in Short-Term Prognosis

Changes in Serum Cardiac Troponin Ilevels after Percutaneous Transluminal Coronary Angioplasty

Significance of plasma PAPP-A and CRP change after percutaneous coronary intervention

Elevated level of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile.